Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Major Funds Amplify Stake in Royal Gold Amid Sector Rally

Robert Sasse by Robert Sasse
December 1, 2025
in Analysis, Commodities, Gold & Precious Metals
0
Royal Gold Stock
0
SHARES
37
VIEWS
Share on FacebookShare on Twitter

A surge of institutional capital is flowing into Royal Gold, a prominent player in the precious metals streaming sector, coinciding with gold prices reaching a six-week peak. Recent regulatory filings have unveiled substantial position increases by major asset managers, with one firm boosting its holdings by over 1,000%. This aggressive accumulation by professional investors comes despite the company’s latest quarterly results missing analyst targets.

Institutional Holdings Reach Dominant Levels

The conviction of large-scale investors is unmistakable. Regulatory disclosures confirm that institutional entities are significantly expanding their equity positions in Royal Gold. The most dramatic move was executed by Neuberger Berman Group LLC, which increased its stake by a staggering 1,124% during the reporting period. The firm now holds nearly 110,000 shares, signaling strong confidence.

This activity is part of a broader trend. Other heavyweight investors, including Legal & General and American Century, have also added to their existing holdings. Collectively, institutional investors now control a substantial 83.65% of the company’s outstanding shares, indicating deep involvement from so-called “smart money.”

Gold’s Momentum Provides Strategic Tailwind

The timing of these investments aligns with a powerful rally in the precious metals market. Gold is approaching a fresh six-week high, fueled by growing market expectations that the U.S. Federal Reserve will initiate interest rate cuts in December. This environment is particularly favorable for Royal Gold’s business model. As a streaming and royalty company, it gains direct exposure to rising metal prices without bearing the operational risks and capital expenditures associated with traditional mining operations.

Should investors sell immediately? Or is it worth buying Royal Gold?

Notably, the recent quarterly figures, which fell short of profit and revenue forecasts, appear to have done little to deter these large investors. Their focus seems to be on the broader picture: a year-over-year revenue increase exceeding 30% and the company’s attractive dividend policy.

Analysts See Further Upside Potential

The fundamental and technical backdrop for Royal Gold remains positive. The share price is consolidating near its annual high, supported by the strength in gold and sustained institutional interest. Market researchers continue to see room for growth. The average price target among analysts stands at $225.40, suggesting an approximate upside potential of 12% from current levels.

A key focus for the trading sessions ahead will be whether the stock can maintain its footing above the psychologically significant $200 threshold. Should the gold rally persist leading into the Fed’s December meeting, Royal Gold may be positioned to challenge its next resistance level.

Ad

Royal Gold Stock: Buy or Sell?! New Royal Gold Analysis from March 25 delivers the answer:

The latest Royal Gold figures speak for themselves: Urgent action needed for Royal Gold investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Royal Gold: Buy or sell? Read more here...

Tags: Royal Gold
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Microsoft Stock
AI & Quantum Computing

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

March 25, 2026
Hesai Group Stock
Analysis

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

March 25, 2026
Pagerduty Inc Stock
AI & Quantum Computing

PagerDuty Charts a New Course with Autonomous AI Systems

March 25, 2026
Next Post
Tilray Stock

Tilray Executes Major Share Consolidation Amid Shifting Institutional Landscape

Amazon Stock

A Surprising Alliance and Record Sales: Amazon's Strategic Moves

PayPal Stock

A Crisis of Confidence: PayPal's Leadership Exodus Overshadows Strong Fundamentals

Recommended

Alphabet Stock

EU Launches Fresh Antitrust Probe Into Alphabet

4 months ago
CarParts.Com Stock

CarParts.com Faces Critical Week Amid Leadership Shakeup and Earnings Release

5 months ago
Peloton Stock

Peloton’s Stock Rollercoaster: Profitability Meets Product Recall

4 months ago
Kraft Heinz Stock

A Radical Breakup: Kraft Heinz Plans Corporate Split to Reverse Fortunes

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution

Watsco’s Dividend Hike Contrasts with Operational Headwinds

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

Trending

Microsoft Stock
AI & Quantum Computing

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

by Jackson Burston
March 25, 2026
0

Microsoft continues to post robust revenue growth, but the cost of maintaining its competitive edge is becoming...

Hesai Group Stock

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

March 25, 2026
Pagerduty Inc Stock

PagerDuty Charts a New Course with Autonomous AI Systems

March 25, 2026
Lexaria Bioscience Stock

Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution

March 25, 2026
Watsco Stock

Watsco’s Dividend Hike Contrasts with Operational Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink
  • Hesai Group’s Milestone Profit Tempered by Cautious Guidance
  • PagerDuty Charts a New Course with Autonomous AI Systems

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com